PHARMAnetwork logo
GLOBAL CDMO & PHARMA OUTSOURCING  
Menu
  • Industry Insights
    • Market Intelligence
    • Corporate Strategy
    • Investments & Capex
    • Finance & M&A
    • Regulatory Affairs
    • Legal & Compliance
  • Magazine
    • Latest Issue
    • Archive
    • Editions
    • Editorial Line
  • Events
  • For advertisers
    • Why PHARMAnetwork
    • MediaKit
    • Contact us
  • About PHARMAnetwork
    • Who We Are
    • Editorial Philosophy
    • Contact us

PHARMAnetwork magazine - last issue

PHARMAnetwork magazine: n°69 July 2026 - Content

Market Intelligence
10 Biopharma in the First Half of 2026
Investment & CAPEX
18 CDMO 2026: A New Industrial Hierarchy Is Emerging
28 Ahead of the Curve: Strategic Investments for Outsourcing Partners
Corporate Strategy
34 Small Batches Sterile Excellence
40 Meribel Pharma Solutions: Building a European CDMO Platform Between Scale and Specialization
Corporate Strategy
44 AI: A New Competitive Factor for CDMOs?
46 The “Augmented” CDMO: Real Transformation or Marketing Narrative?
52 Deviations, CAPA and Batch Records: Where AI Adoption Starts in CDMOs
60 AI Maturity: New Selection Criterion for CDMOs?
Legal
64 AI Clauses in CDMO Contracts: Where to Focus Attention?
Read our last issue

PHARMAnetwork

  • About us
  • Editorial Philosophy
  • Contact

Editorial content

  • Industry Insights
  • Magazine - last issue
  • Events

For advertisers

  • Why PHARMAnetwork
  • Contact us
© 1997-2026 PHARMAnetwork – All rights reserved.
Privacy Policy | Terms of Use
International media on CDMOs & Contract pharmaceutical